ALKERMES | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.25B 40M 2025-06
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
ALKERMES USD 153.87M 17.83M 2025-06
Amgen USD 1.69B 4M 2025-06
Biogen USD 583.8M 11.3M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
J&J USD 5.89B 777M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Merck USD 2.63B 104M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Otsuka Holdings JPY 239.48B 6.99B 2025-06
Pfizer USD 3.42B 406M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06


ALKERMES Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.